Stockscreener 앱 받기
13.81
1.71%
-0.24
시간 외 거래:
13.81
전일 마감가:
$14.05
열려 있는:
$14.11
하루 거래량:
1.32M
Relative Volume:
0.62
시가총액:
$1.41B
수익:
-
순이익/손실:
$-804.34M
주가수익비율:
-1.4676
EPS:
-9.41
순현금흐름:
$-531.06M
1주 성능:
-2.68%
1개월 성능:
-4.50%
6개월 성능:
-64.62%
1년 성능:
-61.62%
1일 변동 폭
$13.76
$14.60
1주일 범위
$13.04
$15.37
52주 변동 폭
$13.04
$55.70
바이오헤이븐 Stock (BHVN) Company Profile
명칭
Biohaven Ltd
전화
203-404-0410
주소
215 CHURCH STREET, NEW HAVEN, CT
BHVN을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BHVN
Biohaven Ltd
|
13.81 | 1.45B | 0 | -804.34M | -531.06M | -9.41 |
|
VRTX
Vertex Pharmaceuticals Inc
|
458.49 | 121.30B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
545.53 | 61.60B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
320.52 | 41.17B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
566.14 | 34.35B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
291.93 | 27.29B | 3.81B | -644.79M | -669.77M | -6.24 |
바이오헤이븐 Stock (BHVN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-05-19 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2025-02-11 | 개시 | Deutsche Bank | Buy |
| 2024-09-16 | 개시 | Jefferies | Buy |
| 2024-09-04 | 개시 | Bernstein | Outperform |
| 2024-07-24 | 개시 | Morgan Stanley | Overweight |
| 2024-02-16 | 개시 | RBC Capital Mkts | Outperform |
| 2024-02-06 | 개시 | UBS | Buy |
| 2023-12-22 | 개시 | H.C. Wainwright | Buy |
| 2023-12-08 | 개시 | Robert W. Baird | Outperform |
| 2023-01-24 | 개시 | SVB Securities | Outperform |
| 2023-01-04 | 개시 | JP Morgan | Overweight |
| 2022-12-02 | 개시 | BTIG Research | Buy |
| 2022-10-26 | 업그레이드 | Cantor Fitzgerald | Neutral → Overweight |
| 2022-10-12 | 개시 | Piper Sandler | Overweight |
| 2022-08-19 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2022-08-08 | 다운그레이드 | Wedbush | Outperform → Neutral |
| 2022-05-11 | 다운그레이드 | SVB Leerink | Outperform → Mkt Perform |
| 2021-10-19 | 재개 | Morgan Stanley | Equal-Weight |
| 2021-08-10 | 다운그레이드 | UBS | Buy → Neutral |
| 2021-08-03 | 재확인 | Canaccord Genuity | Buy |
| 2021-03-11 | 개시 | UBS | Buy |
| 2020-12-15 | 개시 | H.C. Wainwright | Buy |
| 2020-04-17 | 개시 | Cowen | Outperform |
| 2020-02-10 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2020-02-06 | 개시 | Mizuho | Buy |
| 2019-11-22 | 개시 | Wedbush | Outperform |
| 2019-06-25 | 재확인 | Canaccord Genuity | Buy |
| 2019-05-06 | 개시 | Goldman | Buy |
| 2019-04-09 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2019-03-04 | 재확인 | Needham | Buy |
| 2018-07-03 | 재확인 | Needham | Buy |
| 2018-07-02 | 재확인 | Needham | Buy |
| 2018-04-05 | 다운그레이드 | Barclays | Overweight → Equal Weight |
| 2018-02-22 | 재확인 | Canaccord Genuity | Buy |
| 2017-12-15 | 개시 | Canaccord Genuity | Buy |
| 2017-10-03 | 재확인 | Needham | Buy |
모두보기
바이오헤이븐 주식(BHVN)의 최신 뉴스
BHVN Investors Have Opportunity to Lead Biohaven Ltd. Securities Fraud Lawsuit with the Schall Law Firm - Morningstar
Investors who lost money on Biohaven Ltd.(BHVN) should contact The Gross Law Firm about pending Class ActionBHVN - PR Newswire
Biohaven Ltd. Stock Analysis and ForecastFree Stock Chart Pattern Guide - PrintWeekIndia
Is Biohaven Ltd. a good long term investmentConsistent triple returns - PrintWeekIndia
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Biohaven - Stockhouse
Biohaven Ltd. Securities Class Action Lawsuit Filed Over Misleading Statements. - AInvest
ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Biohaven - GlobeNewswire
ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Biohaven Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action – BHVN - GlobeNewswire Inc.
What analysts say about Biohaven Ltd. stockExceptional growth trajectory - Autocar Professional
What drives Biohaven Ltd. stock priceExplosive returns - jammulinksnews.com
Biohaven Ltd. (BHVN) Collaborates with Bexorg, Inc to Target Central Nervous System Disorders - MSN
Lost Money on Biohaven Ltd. (BHVN)? Join Class Action Before September 12, 2025Contact Levi & Korsinsky - ACCESS Newswire
Lost Money on Biohaven Ltd. (BHVN)? Contact Levi & Korsinsky to Join Class Action Before September 12, 2025 - ACCESS Newswire
Kirby McInerney LLP Reminds Biohaven Ltd. (BHVN) Investors of Class Action Filing and Encourages Investors to Contact the Firm - TradingView
BHVN INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces That Biohaven Ltd. Investors With Substantial Losses Have Opportunity to Lead Class Action Lawsuit - The Globe and Mail
Biohaven Ltd. (BHVN) LawsuitInvestors Urged to Contact Levi & Korsinsky Before September 12, 2025 - ACCESS Newswire
Law Offices of Frank R. Cruz Encourages Biohaven Ltd. (BHVN) Investors To Inquire About Securities Fraud Class Action - The Globe and Mail
Class Action Lawsuit Filed: Biohaven Ltd. (BHVN)Join by September 12, 2025Contact Levi & Korsinsky - ACCESS Newswire
Law Offices of Howard G. Smith Encourages Biohaven Ltd. (BHVN) Investors To Inquire About Securities Fraud Class Action - Business Wire
BHVN INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Biohaven Ltd. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - The Malaysian Reserve
Did You Lose Money on Biohaven Ltd. (BHVN)? Levi & Korsinsky Urges Investors to Act Before September 12, 2025 - ACCESS Newswire
Class Action Lawsuit Filed Against Biohaven Ltd. (BHVN)Recover LossesContact Levi & Korsinsky Before September 12, 2025 - ACCESS Newswire
Class Action Alert: Levi & Korsinsky Reminds Biohaven Ltd. (BHVN) Investors of September 12, 2025 Deadline - ACCESS Newswire
September 12, 2025 Deadline: Join Class Action Lawsuit Against Biohaven Ltd. (BHVN)Contact Levi & Korsinsky - ACCESS Newswire
2 Investors who lost money on Biohaven should contact Faruqi & Faruqi about pending Class ActionBHVN - ACCESS Newswire
BIOHAVEN ALERT: Bragar Eagel & Squire, P.C. Announces that - GlobeNewswire
BHVN Investor Notice: Robbins LLP Reminds Biohaven Ltd. Stockholders of the Securities Fraud Class Action Lawsuit - GlobeNewswire
ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Biohaven - GlobeNewswire
Biohaven Faces Investor Fury Over Misleading Claims - TipRanks
Biohaven Ltd. (BHVN) Investors Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation - Business Wire
Biohaven Ltd. (BHVN) Class Action Lawsuit: Levi & Korsinsky Reminds Investors of September 12, 2025 Deadline - ACCESS Newswire
Pomerantz Law Firm Announces the Filing of a Class Action Against Biohaven Ltd. and Certain OfficersBHVN - PR Newswire
BHVN INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Biohaven Ltd. Investors with Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Biohaven: Cash Hog Awaits FDA Decision On SCA - Seeking Alpha
Securities Fraud Investigation Into Biohaven Ltd. (BHVN) Announced – Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz - Business Wire
Rosen Law Firm Urges Biohaven Ltd. (NYSE: BHVN) Stockholders to Contact the Firm for Information About Their Rights - The Malaysian Reserve
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Biohaven - GlobeNewswire
Biohaven, Bexorg Partner to Accelerate CNS Drug Discovery Using Novel Whole-Brain Platform - MSN
BHVN INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire
Shareholder Alert: Robbins LLP Informs Investors of the Biohaven Ltd. Corporation Class Action - Morningstar
Biohaven's Drug Prospects Were Overhyped, Suit Says - Law360
BHVN SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Biohaven Ltd. Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Why Biohaven Ltd. stock attracts strong analyst attentionFree Stock Market Forecasting Tools - Newser
바이오헤이븐 (BHVN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.87%
0.17%
자본화:
|
볼륨(24시간):